|Grant ID: RR190056|
Recruitment of First-Time, Tenure-Track Faculty Members
Massachusetts Institute of Technology
May 15, 2019
Liver cancer is the third leading cause of cancer mortality worldwide and kills more people in Texas than in any other state. Rather than decreasing like many other cancers, the rate of hepatocellular carcinoma has tripled in the last 20 years. Risk factors include obesity, alcohol abuse, and type 2 diabetes, all of which are on the rise.
The disease often has a poor prognosis, and although immune checkpoint therapy can be effective for other cancers, it works poorly in the liver because of the low population of immune cells there.
Now a bioengineer at Rice University is exploring a novel approach to treating liver cancer that has the potential to greatly improve the effectiveness of treatment. Kevin McHugh was recruited to Rice University department of bioengineering from the Massachusetts Institute of Technology, where he was a postdoctoral fellow at the Koch Institute for Integrative Cancer Research. He was recruited in 2019 with the help of a First-Time Tenure-Track Award from CPRIT.